medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2020, Number 4

<< Back Next >>

Arch Neurocien 2020; 25 (4)

Respiratory physiotherapy in patients with Amyotrophic Lateral Sclerosis. A systematic review

Abal-Monteagudo R, Da Cuña-Carrera I, Alonso-Calvete A, González-González Y

Language: Spanish
References: 34
Page: 9-22
PDF size: 312.19 Kb.


ABSTRACT

Introduction: Amyotrophic lateral sclerosis is a central nervous system disease with a progressive degeneration of superior and inferior motor neurons, causing several complications, specially respiratory problems. Respiratory physiotherapy has a great importance in this disease, since it can improve considerably the pulmonary function and gases changes, increasing the air volumes and decreasing the respiratory work, facilitating then the elimination of bronchial secretions. Thus, the aim of this study is to review the scientific literature in the last 5 years about the physiotherapy in ALS patients.
Development: A systematic review was carried out, searching in PubMed and Web of Science with the terms “amyotrophic lateral sclerosis” y “respiratory therapy”. 217 results were obtained, and after the inclusion and exclusion criteria 19 studies were selected. All works analyzed carried out different interventions in respiratory physiotherapy such as VNI, phrenic stimulation, Cough-Assist or exercise therapy.
Conclusions: Respiratory physiotherapy seems to be effective for patients with ALS, except from phrenic stimulation.


REFERENCES

  1. Zapata-Zapata CH, Franco-Dáger E, Solano-Atehortúa JM, Ahunca- Velásquez LF. Esclerosis lateral amiotrófica: actualización. Latreia. 2016; 29(2):194-205. https://www.redalyc.org/pdf/1805/180544647008.pdf

  2. Braun AT, Caballero-Eraso C, Lechtzin N. Amyotrophic Lateral Sclerosis and the Respiratory System. Clin Chest Med. 2018; 39(2):391-400. https://doi.org/10.1016/j.ccm.2018.01.003

  3. Panchabhai TS, Mireles Cabodevila E, Pioro EP, Wang X, Han X, Aboussouan LS. Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation. ERJ Open Res. 2019; 5(3). https://doi.org/10.1183/23120541.00044-2019

  4. Ackrivo J, Hansen-Flaschen J, Wileyto EP, Schwab RJ, Elman L, Kawut SM. Development of a prognostic model of respiratory insufficiency or death in amyotrophic lateral sclerosis. Eur Respir J. 2019; 53(4). https://doi. org/10.1183/13993003.02237-2018

  5. Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014; 50(1):4-13. https://doi. org/ 10.1002/mus.24202

  6. Gonzalez-Bermejo J, Morélot-Panzini C, Tanguy M-L, Meininger V, Pradat P-F, Lenglet T, et al. Early diaphragm pacing in patients with amyotrophic lateral sclerosis (RespiStimALS): a randomised controlled triple-blind trial. Lancet Neurol. 2016; 15(12):1217-27. https://doi.org/10.1016/ S1474-4422(16)30233-2

  7. López JA, Morant P. Fisioterapia respiratoria: indicaciones y técnica. An Pediatr Contin. 2004;2(5):303-6. http://www.sld.cu/galerias/pdf/sitios/ rehabilitacion-adulto/fisioterapiaresp.pdf

  8. van Groenestijn AC, Schröder CD, van Eijk RPA, Veldink JH, Kruitwagen-van Reenen ET, Groothuis JT, et al. Aerobic Exercise Therapy in Ambulatory Patients With ALS: A Randomized Controlled Trial. Neurorehabil Neural Repair. 2019; 33(2):153-64. https://doi. org/10.1177/1545968319826051

  9. Bédard M-E, McKim DA. Daytime Mouthpiece for Continuous Noninvasive Ventilation in Individuals With Amyotrophic Lateral Sclerosis. Respir Care. 2016; 61(10):1341-8. https://doi.org/ 10.4187/respcare.04309

  10. Bertella E, Banfi P, Paneroni M, Grilli S, Bianchi L, Volpato E, et al. Early initiation of night-time NIV in an outpatient setting: a randomized non-inferiority study in ALS patients. Eur J Phys Rehabil Med. 2017; (6). https://www.minervamedica.it/index2.php?show=R33Y2017N06A0892

  11. Terzano C, Romani S. Early use of non invasive ventilation in patients with amyotrophic lateral sclerosis: what benefits? Eur Rev Med Pharmacol Sci. 2015; 19(22):4304-13. https://doi.org/10.1177/2514183X20914183

  12. Sancho J, Bures E, de La Asuncion S, Servera E. Effect of High- Frequency Oscillations on Cough Peak Flows Generated by Mechanical In-Exsufflation in Medically Stable Subjects With Amyotrophic Lateral Sclerosis. Respir Care. 2016; 61(8):1051-8. https://doi.org/10.4187/ respcare.04552

  13. Elamin EM, Wilson CS, Sriaroon C, Crudup B, Pothen S, Kang YC, et al. Effects of early introduction of non-invasive positive pressure ventilation based on forced vital capacity rate of change: Variation across amyotrophic lateral sclerosis clinical phenotypes. Int J Clin Pract. 2019; 73(1):e13257. https://doi.org/10.1111/ijcp.13257

  14. Magalhães CM, Fregonezi GA, Vidigal-Lopes M, Vieira BSPP, Vieira DSR, Parreira VF. Effects of non-invasive ventilation and posture on chest wall volumes and motion in patients with amyotrophic lateral sclerosis: a case series. Braz J Phys Ther. 2016;20(4):336-44. https://doi.org/10.1590/ bjpt-rbf.2014.0164

  15. Boentert M, Brenscheidt I, Glatz C, Young P. Effects of non-invasive ventilation on objective sleep and nocturnal respiration in patients with amyotrophic lateral sclerosis. J Neurol. 2015; 262(9):2073-82. https:// doi.org/10.1016/S1474-4422(05)70326-4

  16. Crescimanno G, Greco F, Arrisicato S, Morana N, Marrone O. Effects of positive end expiratory pressure administration during non-invasive ventilation in patients affected by amyotrophic lateral sclerosis: A randomized crossover study: Effects of PEEP during NIV in ALS. Respirology. 2016; 21(7):1307-13. https://doi.org/10.1111/resp.12836

  17. Vitacca M, Montini A, Lunetta C, Banfi P, Bertella E, De Mattia E, et al. Impact of an early respiratory care programme with non-invasive ventilation adaptation in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018; 25(3):556-e33. https://doi.org/10.1111/ene.1354718.

  18. Burkhardt C, Neuwirth C, Sommacal A, Andersen PM, Weber M. Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients. Zhou R, editor. PLOS ONE. 2017; 12(5):e0177555. https://doi.org/10.1371/journal. pone.0177555

  19. Vrijsen B, Buyse B, Belge C, Robberecht W, Van Damme P, Decramer M, et al. Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study. J Clin Sleep Med. 2015; 11(05):559-66. https://doi.org/10.5664/jcsm.4704

  20. Vandoorne E, Vrijsen B, Belge C, Testelmans D, Buyse B. Noninvasive ventilation in amyotrophic lateral sclerosis: effects on sleep quality and quality of life. Acta Clin Belg. 2016; 71(6):389-94. https://doi.org/10.1 080/21678421.2020.1844755

  21. Dorst J, Behrendt G, Ludolph AC. Non-invasive ventilation and hypercapnia-associated symptoms in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019; 139(2):128-34. https://doi.org/10.1111/ ane.13043

  22. De Mattia E, Falcier E, Lizio A, Lunetta C, Sansone VA, Barbarito N, et al. Passive Versus Active Circuit During Invasive Mechanical Ventilation in Subjects With Amyotrophic Lateral Sclerosis. Respir Care. 2018; 63(9):1132-8. https://doi.org/10.4187/respcare.05866

  23. Vrijsen B, Testelmans D, Belge C, Vanpee G, Van Damme P, Buyse B. Patient-ventilator asynchrony, leaks and sleep in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2016; 17(5- 6):343-50. https://doi.org/10.3109/21678421.2016.1170149

  24. Vrijsen B, Buyse B, Belge C, Vanpee G, Van Damme P, Testelmans D. Randomized cross-over trial of ventilator modes during non-invasive ventilation titration in amyotrophic lateral sclerosis: NIV modes in ALS. Respirology. 2017; 22(6):1212-8. https://doi.org/ 10.1111/resp.13046

  25. McDermott C, Shaw P, Cooper C, Dixon S, Baird W. Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial. Lancet Neurol. 2015; 14(9):883-92. https:// doi.org/10.1016/S1474-4422(15)00152-0

  26. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. https://doi. org/ 10.1016/0197-2456(95)00134-4

  27. Donado Gómez JH, Higuita Duque LN, Castro Palacio JJ. Limitaciones más frecuentes en los ensayos clínicos con Asignación Aleatoria (ECA) en el área de medicina interna. Rev Med. 2015; 23(2):35. http://www.scielo. org.co/scielo.php?pid=S0121-52562015000200004&script=sci_ abstract&tlng=es

  28. Manzano Juárez A, González Céspedes MD, Rocha Honor E, Sánchez Beteta MP. Esclerosis Lateral Amiotrófica, presentación atípica. Rev Clínica Med Fam. 2015; 8(3):251-3. http://dx.doi.org/10.4321/S1699- 695X2015000300010

  29. Díaz P O. II. Efectos Fisiológicos de la Ventilación no Invasiva. Rev Chil Enfermedades Respir. 2008; 24(3):177-84. http://dx.doi.org/10.4067/ S0717-73482008000300002

  30. Quarracino C, Rey RC, Rodríguez GE. Esclerosis lateral amiotrófica (ELA): seguimiento y tratamiento. Neurol Argent. 2014; 6(2):91-5. https://doi. org/10.1016/j.neuarg.2014.02.004

  31. Sancho J, Candela A, Gómez E, León M, Doménech R, Ferreres J, et al. Guía para el manejo de los problemas respiratorios de la ELA. 1a. Valencia: Sociedad Valenciana de Neumología; 2019. http://www. elaandalucia.es/WP/wp-content/uploads/Gu%C3%ADa-para-el- Manejo-de-los-Problemas-Respiratorios-en-la-ELA.pdf

  32. Proceso asistencial integrado de Esclerosis lateral amiotrófica. Santiago de Compostela: Xunta de Galicia; 2018. https://libraria.xunta.gal/es/ proceso-asistencial-integrado-de-esclerosis-lateral-amiotrofica

  33. Barrera Chacón JM, Benítez Moya JM, Boceta Osuna J, Caballero Eraso C, Camino León R, Carrasco Cárdenas V, et al. Documento de consenso para la atención a los pacientes con Esclerosis Lateral Amiotrófica. Sevilla: Consejería de Salud; 2017. https://www.repositoriosalud.es/ handle/10668/2855

  34. Escala de Clasificación Funcional de ELA - Esclerosis Lateral Amiotrófica -Compendio de Información. https://sites.google.com/site/vicortega2/ home/que-es-la-ela/escala




2020     |     www.medigraphic.com